Virtual Reality Therapy for Anxiety

N/A

Recruiting

Led By Tsai Jack, PhD

Research Sponsored by The University of Texas Health Science Center, Houston

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Must not have

Reports stereoscopic vision or balance problems

Timeline

Screening 3 weeks

Treatment Varies

Follow Up week 1(session1 and session 2), week 2( session 3 and session 4), week 3 (session 5 and session 6)

Awards & highlights

No Placebo-Only Group

Summary

This trial will test if a VR intervention can help reduce anxiety symptoms in college students, by having them undergo six VR sessions over the course of three weeks.

Who is the study for?

This trial is for students at The University of Texas Health Science Center School of Public Health San Antonio campus who can speak English and have a mild level of anxiety. Students with photosensitive epilepsy, vision or balance issues, or those currently in therapy for anxiety or who were treated within the last year cannot participate.

What is being tested?

The study is testing 'gameChange', a virtual reality therapy program, to see if it helps reduce anxiety symptoms over six sessions within three weeks. It also looks at how this VR treatment might improve students' confidence in their academic abilities.

What are the potential side effects?

Since this intervention involves virtual reality, some participants may experience temporary discomfort like dizziness, nausea, or headaches during the VR sessions.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I experience issues with my vision or balance.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ week 1(session1 and session 2), week 2( session 3 and session 4), week 3 (session 5 and session 6)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~week 1(session1 and session 2), week 2( session 3 and session 4), week 3 (session 5 and session 6)

This trial's timeline: 3 weeks for screening, Varies for treatment, and week 1(session1 and session 2), week 2( session 3 and session 4), week 3 (session 5 and session 6) for reporting.